Owens & Minor’s Q1 2025 Financial Performance Overview

Owens & Minor ( (OMI) ) has released its Q1 earnings. Here is a breakdown of the information Owens & Minor presented to its investors.

Owens & Minor, Inc. is a global healthcare solutions company that provides essential products and services to support care from hospitals to homes, with a focus on enhancing patient outcomes and healthcare efficiency.

In its first quarter of 2025 financial results, Owens & Minor reported a slight increase in revenue compared to the previous year, driven by growth in its Patient Direct segment. The company also highlighted an expansion in operating margins within this segment and reaffirmed its financial guidance for the year.

Key financial metrics for the quarter included a revenue of $2.63 billion, a slight increase from $2.61 billion in the same period last year. The Patient Direct segment showed mid-single-digit growth, contributing significantly to a mid-teen expansion in EBITDA. However, the company reported a net loss of $25 million, slightly higher than the previous year’s loss, while adjusted net income improved to $18.1 million from $14.9 million. The company is also actively engaged in the potential sale of its Products & Healthcare Services segment.

Looking forward, Owens & Minor remains optimistic about the growth prospects of its Patient Direct segment and plans to focus on disciplined capital deployment and strategic acquisitions. The company aims to navigate potential changes in government policy while integrating its planned acquisition of Rotech, maintaining a positive outlook for the remainder of 2025.